Education

Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing

Quality Improvement Program Webinar—NSCLC Biomarker Testing

Lung Cancer Patient with 3 EGFR Mutations

Ovarian Cancer Patient with Somatic BRCA1 Reversion Mutation

Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations

NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients

Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result

NSCLC Patient and Adjuvant Chemotherapy

Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results

Patient with NSCLC Who Recurred within a Year

Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy